Bernie Sanders Accuses Drugmaker Of ‘Fleecing’ Americans With Staggering $375,000 List Price For Drug That Was Once Free

Patients suffering from a rare disorder previously were able to obtain the treatment for free from a small pharmaceutical company that offered it through an FDA program called “compassionate use.” In November, the FDA allowed Catalyst to distribute the drug, with exclusive rights to market it. The following month the company said it would sell Firdapse for $375,000 a year. In other news, lawmakers are inviting CEOs from seven major drug companies to testify on prices.

from Kaiser Health News http://bit.ly/2S98XuS